Analysis of vasodepressor responses to nociceptin and nociceptin analogs in the systemic vascular bed of the anesthetized rabbit in vivo

H. C. Champion, Trinity Bivalacqua, A. Rauchwarger, S. M. McWilliams, D. B. McNamara, P. J. Kadowitz

Research output: Contribution to journalArticle

Abstract

Background: The heptadecapeptide nociceptin, also known as Orphanin FQ, is a recently discovered endogenous ligand for the opioid-like G-protein- coupled receptor ORL1. Methods and Results: In the present study, responses to nociceptin, [Tyr1]-nociceptin, nociceptin-(2-17), nociceptin-(1-11), and nociceptin-(1-7) were compared in the systemic vascular bed of the rabbit. Nociceptin and [Tyr1]-nociceptin induced dose related decreases in systemic arterial pressure (SAP) when injected in doses of 1-30 nmol/kg intravenous (IV); in terms of relative vasodepressor activity, [Tyr1]-nociceptin and nociceptin were similar in potency. However, nociceptin-(2-17), nociceptin- (1-11), and nociceptin-(1-7) had no effect on SAP when injected in doses up to 30 nmol/kg IV. The decreases in SAP in response to nociceptin and [Tyr1]- nociceptin were not altered by the opioid receptor antagonist naloxone at a time when depressor responses to methionine-enkephalin were reduced significantly. Conclusions: The results of the present study show that vasodepressor responses to nociceptin and [Tyr1]-nociceptin are mediated by the activation of a naloxone-insensitive opioid receptor and are not dependent on the presence of Phe at the N-terminus of the nociceptin sequence. Moreover, the present results show that nociceptin-(2-17), nociceptin-(1-11), and nociceptin-(1-7) do not alter SAP in the rabbit, indicating that peptide chain length is important for the expression of vasodepressor activity.

Original languageEnglish (US)
Pages (from-to)247-252
Number of pages6
JournalJournal of Cardiovascular Pharmacology and Therapeutics
Volume3
Issue number3
StatePublished - 1998
Externally publishedYes

Fingerprint

Blood Vessels
Rabbits
Arterial Pressure
nociceptin
Naloxone
Methionine Enkephalin
Narcotic Antagonists
Opioid Receptors
G-Protein-Coupled Receptors
Opioid Analgesics

Keywords

  • Opioid receptors
  • Orphanin FQ
  • Vasodepressor activity

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pharmacology

Cite this

Analysis of vasodepressor responses to nociceptin and nociceptin analogs in the systemic vascular bed of the anesthetized rabbit in vivo. / Champion, H. C.; Bivalacqua, Trinity; Rauchwarger, A.; McWilliams, S. M.; McNamara, D. B.; Kadowitz, P. J.

In: Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 3, No. 3, 1998, p. 247-252.

Research output: Contribution to journalArticle

@article{06e4332818034550bacefd94ea9dee86,
title = "Analysis of vasodepressor responses to nociceptin and nociceptin analogs in the systemic vascular bed of the anesthetized rabbit in vivo",
abstract = "Background: The heptadecapeptide nociceptin, also known as Orphanin FQ, is a recently discovered endogenous ligand for the opioid-like G-protein- coupled receptor ORL1. Methods and Results: In the present study, responses to nociceptin, [Tyr1]-nociceptin, nociceptin-(2-17), nociceptin-(1-11), and nociceptin-(1-7) were compared in the systemic vascular bed of the rabbit. Nociceptin and [Tyr1]-nociceptin induced dose related decreases in systemic arterial pressure (SAP) when injected in doses of 1-30 nmol/kg intravenous (IV); in terms of relative vasodepressor activity, [Tyr1]-nociceptin and nociceptin were similar in potency. However, nociceptin-(2-17), nociceptin- (1-11), and nociceptin-(1-7) had no effect on SAP when injected in doses up to 30 nmol/kg IV. The decreases in SAP in response to nociceptin and [Tyr1]- nociceptin were not altered by the opioid receptor antagonist naloxone at a time when depressor responses to methionine-enkephalin were reduced significantly. Conclusions: The results of the present study show that vasodepressor responses to nociceptin and [Tyr1]-nociceptin are mediated by the activation of a naloxone-insensitive opioid receptor and are not dependent on the presence of Phe at the N-terminus of the nociceptin sequence. Moreover, the present results show that nociceptin-(2-17), nociceptin-(1-11), and nociceptin-(1-7) do not alter SAP in the rabbit, indicating that peptide chain length is important for the expression of vasodepressor activity.",
keywords = "Opioid receptors, Orphanin FQ, Vasodepressor activity",
author = "Champion, {H. C.} and Trinity Bivalacqua and A. Rauchwarger and McWilliams, {S. M.} and McNamara, {D. B.} and Kadowitz, {P. J.}",
year = "1998",
language = "English (US)",
volume = "3",
pages = "247--252",
journal = "Journal of Cardiovascular Pharmacology and Therapeutics",
issn = "1074-2484",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - Analysis of vasodepressor responses to nociceptin and nociceptin analogs in the systemic vascular bed of the anesthetized rabbit in vivo

AU - Champion, H. C.

AU - Bivalacqua, Trinity

AU - Rauchwarger, A.

AU - McWilliams, S. M.

AU - McNamara, D. B.

AU - Kadowitz, P. J.

PY - 1998

Y1 - 1998

N2 - Background: The heptadecapeptide nociceptin, also known as Orphanin FQ, is a recently discovered endogenous ligand for the opioid-like G-protein- coupled receptor ORL1. Methods and Results: In the present study, responses to nociceptin, [Tyr1]-nociceptin, nociceptin-(2-17), nociceptin-(1-11), and nociceptin-(1-7) were compared in the systemic vascular bed of the rabbit. Nociceptin and [Tyr1]-nociceptin induced dose related decreases in systemic arterial pressure (SAP) when injected in doses of 1-30 nmol/kg intravenous (IV); in terms of relative vasodepressor activity, [Tyr1]-nociceptin and nociceptin were similar in potency. However, nociceptin-(2-17), nociceptin- (1-11), and nociceptin-(1-7) had no effect on SAP when injected in doses up to 30 nmol/kg IV. The decreases in SAP in response to nociceptin and [Tyr1]- nociceptin were not altered by the opioid receptor antagonist naloxone at a time when depressor responses to methionine-enkephalin were reduced significantly. Conclusions: The results of the present study show that vasodepressor responses to nociceptin and [Tyr1]-nociceptin are mediated by the activation of a naloxone-insensitive opioid receptor and are not dependent on the presence of Phe at the N-terminus of the nociceptin sequence. Moreover, the present results show that nociceptin-(2-17), nociceptin-(1-11), and nociceptin-(1-7) do not alter SAP in the rabbit, indicating that peptide chain length is important for the expression of vasodepressor activity.

AB - Background: The heptadecapeptide nociceptin, also known as Orphanin FQ, is a recently discovered endogenous ligand for the opioid-like G-protein- coupled receptor ORL1. Methods and Results: In the present study, responses to nociceptin, [Tyr1]-nociceptin, nociceptin-(2-17), nociceptin-(1-11), and nociceptin-(1-7) were compared in the systemic vascular bed of the rabbit. Nociceptin and [Tyr1]-nociceptin induced dose related decreases in systemic arterial pressure (SAP) when injected in doses of 1-30 nmol/kg intravenous (IV); in terms of relative vasodepressor activity, [Tyr1]-nociceptin and nociceptin were similar in potency. However, nociceptin-(2-17), nociceptin- (1-11), and nociceptin-(1-7) had no effect on SAP when injected in doses up to 30 nmol/kg IV. The decreases in SAP in response to nociceptin and [Tyr1]- nociceptin were not altered by the opioid receptor antagonist naloxone at a time when depressor responses to methionine-enkephalin were reduced significantly. Conclusions: The results of the present study show that vasodepressor responses to nociceptin and [Tyr1]-nociceptin are mediated by the activation of a naloxone-insensitive opioid receptor and are not dependent on the presence of Phe at the N-terminus of the nociceptin sequence. Moreover, the present results show that nociceptin-(2-17), nociceptin-(1-11), and nociceptin-(1-7) do not alter SAP in the rabbit, indicating that peptide chain length is important for the expression of vasodepressor activity.

KW - Opioid receptors

KW - Orphanin FQ

KW - Vasodepressor activity

UR - http://www.scopus.com/inward/record.url?scp=0032429380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032429380&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0032429380

VL - 3

SP - 247

EP - 252

JO - Journal of Cardiovascular Pharmacology and Therapeutics

JF - Journal of Cardiovascular Pharmacology and Therapeutics

SN - 1074-2484

IS - 3

ER -